Population A: lower need
Good service access and comparatively better baseline health.
HealthEconomics.wiki · Interactive explorer
Allocate a fixed healthcare budget across three fictional populations. Compare total health gained with who receives the gains, then change the fairness principle and examine why reasonable choices can differ.
Efficiency asks how much health the budget produces. Equity asks whether the distribution of resources and outcomes is fair. The answer depends partly on which differences between people are treated as ethically relevant.
The selected principle changes the question highlighted by the explorer. It does not automatically decide the allocation.
Equal allocation treats identical budget shares as the relevant form of fairness. Examine whether equal inputs produce fair outcomes when needs, barriers and capacity to benefit differ.
Move each control or choose a preset. Health yield represents the expected QALYs produced by one budget unit before rounding.
Good service access and comparatively better baseline health.
Greater health need and substantial geographic barriers to care.
Highest health need, worst baseline health and moderate access barriers.
The measures describe different features of the same allocation. None is a complete measure of fairness by itself.
Horizontal bars show QALYs gained by each fictional population under the selected allocation.
Equal budget shares produce unequal health gains because the populations have different expected health yields.
Under equal allocation, the relevant question is whether identical inputs are fair despite different needs and barriers.
Try this: Select “Most total health,” then compare who receives the gain and who receives none.
Expected health gain equals allocated budget units multiplied by the fictional health yield for each population. The maximum-health comparison allocates all 60 units to the population with the highest health yield. This deliberately simplified model makes the distributional tension visible; real analyses require evidence about feasible scale, diminishing returns, subgroup effects, uncertainty and opportunity costs.